TRIS(2-((2,4,8,10-TETRA-TERT- BUTYLDIBENZO(D,F)(1,3,2)DIOXAPHOSPHEPIN-6-YL)OXY)ETHYL)AMINE
UNII LJ3N6AAU2G
Substance Identification & Data
This profile provides standardized clinical and technical data for Tris(2-((2,4,8,10-tetra-tert- Butyldibenzo(d,f)(1,3,2)dioxaphosphepin-6-yl)oxy)ethyl)amine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LJ3N6AAU2G.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80410-33-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C90H132NO9P3 YAGPRJYCDKGWJR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tris(2-((2,4,8,10-tetra-tert- Butyldibenzo(d,f)(1,3,2)dioxaphosphepin-6-yl)oxy)ethyl)amine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.